Bacterial DNA methyltransferase shields tuberculosis bacteria from oxidative stress

Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), remains a major global health threat in part because the bacterium can withstand damaging reactive oxygen species (ROS) produced by the host. ROS both damage molecules inside cells and act as signaling messengers, so how a pathogen controls ROS levels is critical to its survival. Previous work showed that when DNA methylation is disturbed, Mtb becomes less virulent, but the roles of individual DNA methyltransferases in protecting mycobacteria from oxidative stress were not clear. In the study led by Jianping Xie, researchers focused on a mycobacterial protein called Rv3204 and its possible role in ROS homeostasis. Using the non-pathogenic relative Mycobacterium smegmatis, they deleted the gene homologous to Rv3204 (Ms_1939) and compared the modified strain to normal bacteria. The goal was to test whether Rv3204 functions as a DNA methyltransferase and whether it helps bacteria survive under oxidative stress and during antibiotic exposure. The experiments were designed to link epigenetic modification of DNA to the bacterium’s ability to manage ROS and repair damage.

The team found that Rv3204 functions as an N 4 -methylcytosine (m 4 C) DNA methyltransferase. Deleting the Rv3204 homolog Ms_1939 in Mycobacterium smegmatis produced clear consequences: the mutant strain showed significantly impaired survival when exposed to rifampicin, and it accumulated higher intracellular ROS levels than the wild type. The Ms_1939 deletion strain failed to upregulate transcription of ROS detoxification genes that would normally help neutralize oxidative stress. In addition, the mutant had downregulated expression of DNA repair genes and proved more susceptible to fluoroquinolone antibiotics, specifically norfloxacin and ofloxacin. Measurements also revealed elevated levels of DNA damage in the deletion strain. The authors note this is the first study to establish a direct link between an m 4 C DNA methyltransferase and ROS homeostasis in mycobacteria. Raw data supporting the study have been deposited in NCBI GEO under accession GSE139646.

These findings point to a previously unexplored connection between DNA methylation and the ability of mycobacteria to survive oxidative stress. By showing that Rv3204 is an N 4 -methylcytosine (m 4 C) DNA methyltransferase that influences ROS levels, antioxidant gene activation, DNA repair, and antibiotic susceptibility, the work positions Rv3204 as a potential novel therapeutic target in Mycobacterium tuberculosis. If drugs or other interventions could inhibit Rv3204’s activity or mimic the effects of the Ms_1939 deletion, they might tip the bacterium’s redox balance toward damage and make it more vulnerable to existing antibiotics. More broadly, the study expands our understanding of how epigenetic regulation via m 4 C methylation contributes to bacterial stress adaptation, highlighting a new angle for efforts to disrupt Mtb survival mechanisms and enhance the efficacy of current treatments.